Purelab’s Regional Reference Laboratory for Infectious Diseases (RLID-AD), a subsidiary of PureHealth, the region’s largest integrated healthcare platform, has been recognized by the World Health Organization (WHO) for its contribution to strengthening laboratory capacity in the Eastern Mediterranean region.
The RLID-AD (also known as the Surveillance Laboratory) recently won top honors at the 3rd Scientific Session of the WHO Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) Network in Muscat.
According to Purehealth, the lab has played a key role in the region’s ability to detect and trace infectious diseases, especially during the COVID-19 pandemic.
PureHealth operates more than 25 hospitals, more than 100 clinics, more than 160 laboratories, multiple diagnostic centers, insurance solutions, pharmacy, health technology, procurement, investment and related businesses in the UAE.
RLID-AD gained international reputation for its support in sequencing the SARS-CoV-2 strain during the pandemic. The laboratory provides sequencing capacity to different countries with limited laboratory resources and expertise, enabling the detection and monitoring of strains prevalent in these countries.
This latest recognition is in line with Abu Dhabi’s efforts throughout the pandemic, as it was named the most resilient in the world by Deep Knowledge Analytics (DKA), the London-based DeepTech analytics subsidiary of Deep Knowledge Group (DKG). Strong City for two consecutive years from 2020 to 2022.
The recognition reflects the emirate’s comprehensive, efficient and timely response to the COVID-19 pandemic, reinforcing Abu Dhabi’s healthcare sector as a leading example regionally and internationally.
Dr Farida Al Hosani, Executive Director, Communicable Diseases Unit, Abu Dhabi Public Health Center, said: “This recognition is an important sign of our commitment to the people of Abu Dhabi to provide them with world-class hygiene practices. The results of the collaboration between AD to expand testing capabilities that have proven their value during the pandemic.”
“We are honored to receive this recognition and will continue to strengthen surveillance and testing for infectious diseases. We believe this is a critical component of infectious disease preparedness plans,” he noted.
Arindam Haldar, CEO of Purelab, said: “We are committed to improving public health outcomes and are honored to be recognized by the World Health Organization. This is in line with the PureHealth Group’s mandate, vision and commitment to deliver the best laboratories and laboratory standards. Diagnostic Services Shaping medical outcome.”
“This recognition is a recognition of the standards set at Group level. We will continue to strengthen laboratory capabilities in the Eastern Mediterranean region and support our partners in the fight against the spread of infectious diseases,” he said.
Since its designation as a National Influenza Center in 2017, RLID-AD has played a key role in establishing influenza surveillance at the national level and has worked with WHO and the US Centers for Disease Control and Prevention (CDC) to help detect and prevent influenza, he added. spread of the virus in the region.
Purelab Chief Medical Officer Dr Zain Al Yafei said RLID-AD is committed to providing cutting-edge laboratory services to ensure the highest quality of patient care in the region.
He added: “We are grateful for the endorsement by the World Health Organization as it motivates us to continue our efforts to provide high-quality laboratory services to help control and prevent the spread of infectious diseases in the region.”– trade arab news agency